DB Insurance Co., Ltd. (KRX:005830)

Inozyme Pharma Revenue

DB Insurance had revenue of 4.89T KRW in the quarter ending March 31, 2025, with 9.02% growth. This brings the company's revenue in the last twelve months to 18.72T, up 7.20% year-over-year. In the year 2024, DB Insurance had annual revenue of 18.32T with 6.09% growth.

• Revenue (ttm): 18.72T
• Revenue Growth: +7.20%
• P/S Ratio: 0.41
• Revenue / Employee: 4.21B
• Employees: 4,442
• Market Cap: 7,661.55B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	18.32T	1,051.78B	6.09%
Dec 31, 2023	17.27T	837.39B	5.10%
Dec 31, 2022	16.43T	-1,638.81B	-9.07%
Dec 31, 2021	18.07T	313.63B	1.77%
Dec 31, 2020	17.75T	1,317.88B	8.02%